In view of the joint global efforts of advancing collaborative research in diagnostics, therapeutics, and vaccination in the fight against the COVID-19 (SARS-CoV-2) pandemic, Bio-Helix has specifically developed the LifeDireX COVID-19 RT-qPCR Detection Kit for human respiratory tract specimens. The kit is characterized by: (1) High specificity for the RdRP and N target markers (2) Data obtained in less than 2 hours; and (3) Compatible with standard RT-qPCR machines (ABI 7500, Bio-Rad CFX96, QuantStudio’s 7 Flex).